Results 31 to 40 of about 34,514 (296)

Patient‐Reported Outcomes in a Multidisciplinary Electrophysiology‐Psychology Ventricular Arrhythmia Clinic

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Ventricular arrhythmias (VAs) and their treatment have been associated with psychological distress and diminished quality of life (QOL).
Uday Sandhu, Andrew T. Nguyen, John Dornblaser, Andrew Gray, Karen Paladino, Charles A Henrikson, Adrienne H. Kovacs, Babak Nazer   +7 more
doaj   +1 more source

Depressive disorders in a group of patients after implantation of a cardioverter-defibrillator

, 2023
Introduction: Implantation of a cardioverter-defibrillator, used for primary and secondary prevention of sudden cardiac arrest, can lead to depres-sive disorders among some patients, which often results in a worse course of the underlying disease and ...
Agata Reczek, Joanna Jamka, Reczek, Agata, Czyżowicz, Katarzyna, Katarzyna A. Czyżowicz, Jamka, Joanna   +5 more
core   +1 more source

First Case Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator

JACC: Case Reports, 2023
Electromagnetic interference (EMI) between implantable left ventricular assist devices and cardiac implantable electronic devices has been observed. We demonstrated the first case of EMI between a percutaneous ventricular assist device and an implantable
Kosuke Takahari, MD, Takafumi Oka, MD, PhD, Takayuki Sekihara, MD, Kentaro Ozu, MD, Yasuhiro Akazawa, MD, PhD, Daisuke Nakamura, MD, Isamu Mizote, MD, PhD, Tomohito Ohtani, MD, PhD, Shungo Hikoso, MD, PhD, Yasushi Sakata, MD, PhD   +9 more
doaj   +1 more source

Stepwise cardiac rehabilitation adjustment after exercise-induced implantable cardioverter defibrillator shock: a case report

Journal of Rehabilitation Medicine - Clinical Communications
Objective: To report an in-hospital cardiac rehabilitation strategy after exercise-induced implantable cardioverter defibrillator shock. Case report: A 72-year-old man with heart failure, peripheral artery disease, a history of percutaneous coronary ...
Hidetoshi Yanagi, Harumi Konishi, Saori Yamada, Kazuya Yamamoto, Fumiyuki Otsuka   +4 more
doaj   +1 more source

Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy

Archives of Medical Science, 2021
Introduction Implantable cardioverter defibrillators register various types of arrhythmias. Thus they can be exploited to better identify patients with atrial fibrillation episodes and increase the proportion of patients who may benefit from ...
Barbara Dominik, Przemyslaw Mitkowski, Wojciech Zorawski, Ilona Kowalik, Adam Ciesielski   +4 more
doaj   +1 more source

Evidence regarding clinical use of microvolt T-wave alternans [Accuracy of microvolt T-wave alternans testing]

, 2011
Background: Microvolt T-wave alternans (MTWA) testing in many studies has proven to be a highly accurate predictor of ventricular tachyarrhythmic events (VTEs) in patients with risk factors for sudden cardiac death (SCD) but without a prior history of ...
Hohnloser, Stefan H., Cohen, Richard J., Ikeda, Takanori   +2 more
core   +1 more source

External validation of the BAN‐ADHF diuretic‐resistance score in the DAPA‐RESIST clinical trial

British Journal of Clinical Pharmacology, EarlyView.
Diuretic resistance in worsening heart failure (HF) is associated with poorer outcomes and, although common, can be challenging to identify. The recently developed BAN‐ADHF score can potentially identify patients with worsening HF at risk of diuretic resistance.
Dominic M. Alfonso, Kieran F. Docherty, Matthew M. Y. Lee, Patrick B. Mark, Alex McConnachie, Joanna Osmanska, Bethany Stanley, Atefeh Talebi, Mark C. Petrie, John J. V. McMurray, Ross T. Campbell   +10 more
wiley   +1 more source

S-ICD oversensing detected by remote monitoring using a new atrial fibrillation diagnostic algorithm

Indian Pacing and Electrophysiology Journal, 2018
A 64-year-old male with a high body mass index, and subcutaneous implantable cardioverter defibrillator, (S-ICD) presented with a remote transmission of inappropriately diagnosed AF episodes, due to oversensing of P and T waves.
Christopher Monkhouse, Andre Jacinto, Pier D. Lambiase   +2 more
doaj   +1 more source

Clinical and Echocardiographic Outcomes After Implantation of the ALLEGRA Transcatheter Valve Using the Fully Repositionable IMPERIA Delivery System: One‐Year Results of the EMPIRE I Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz, Claire B. Ren, Christof Burgdorf, Christian Frerker, Ignacio Cruz‐González, Joan Antoni Gómez, José Maria Hernândez, Pilar Jimenez, Ernest Spitzer, Pim Tonino, Pieter Vriesendorp, Nicolas van Mieghem, Samuel Copt, Anders Jönsson, Keith G. Oldroyd, Nicolas Doll   +15 more
wiley   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source